Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas. (Q43456888)
Jump to navigation
Jump to search
scientific article published on 9 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas. |
scientific article published on 9 January 2009 |
Statements
Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas (English)
Mats Jerkeman
Heidi Nyman
Marja-Liisa Karjalainen-Lindsberg
1 reference